NCT05560880

Brief Summary

Over 90% of persons with MS (pwMS) complain of difficulty with walking. High intensity interval gait training (HIIGT), where persons alternate brief periods of walking at high speeds with periods of rest has been found to improve walking in other neurologic diagnoses. However its impact on pwMS is not known. Most gait training in MS is done continuously at a slower pace. The purpose of this study is to compare the effects of HIIGT to traditional Moderate Intensity Continuous Gait Training (MICGT) in pwMS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 30, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

October 6, 2022

Status Verified

September 1, 2022

Enrollment Period

1.3 years

First QC Date

September 22, 2022

Last Update Submit

October 5, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in Six minute walk test time from before to after the intervention

    Subjects will walk for six minutes at their best comfortable pace. They will be guarded by physical therapist for the entire walk. Total distance, distance per minute, and heart rate will be measured.

    The test will be administered to all subjects one week before and one week after the intervention.The test will be administered to all subjects one week before and one week after the intervention.

Secondary Outcomes (3)

  • Change in Functional gait assessment score from before to after the intervention

    Will be done in the week before and the week after the intervention.Will be done in the week before and the week after the intervention.

  • Change in Hand held dynamometry values from before to after the intervention

    Will be done the week before and the week after the intervention.

  • Change in Multiple sclerosis impact scale 29 from before to afterthe intervention

    Performed in the week before and the week after the intervention.

Study Arms (2)

High Intensity Interval gait training

EXPERIMENTAL

subjects will receive 3x/week high intensity interval training for 20 minutes over a 4 week period

Behavioral: High Intensity Interval Gait training

Moderate intensity continuous gait training

ACTIVE COMPARATOR

subjects will receive 3x/week moderate intensity continuous gait training for 20 minutes over a 4 week period

Behavioral: Moderate Intensity Interval gait training

Interventions

Subjects will walk as fast as they can for 30 seconds, followed by a 60 second seated recovery. They will be guarded by a physical therapist at all times.

High Intensity Interval gait training

subjects will walk for 20 minutes at theri best comfortable pace

Moderate intensity continuous gait training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons diagnosed with Multiple Sclerosis.
  • The ability to walk for 6 minutes continuously with or without assistive device.
  • The ability to read, understand and sign a consent form so that they are able to understand the study we are doing
  • Above the age of 18

You may not qualify if:

  • Any cardiopulmonary, orthopedic, or non-MS neurologic disease as we are only examining the effects of MS and need to rule out the impact of other conditions
  • Report of a recent exacerbation. Rationale: the impact of the rationale can interfere with the impact of the independent variables

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hunter College

New York, New York, 11238, United States

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Herb Karpatkin, DSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

September 22, 2022

First Posted

September 30, 2022

Study Start

September 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

October 6, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations